{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:41:22Z","timestamp":1794904882515,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["RCP-2020\\11"],"award-info":[{"award-number":["RCP-2020\\11"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000395","name":"Royal College of Physicians","doi-asserted-by":"publisher","award":["RCP-2020\\11"],"award-info":[{"award-number":["RCP-2020\\11"]}],"id":[{"id":"10.13039\/501100000395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ES\/L009250\/1"],"award-info":[{"award-number":["ES\/L009250\/1"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the contributors to self-rated health in people with late-stage Parkinson\u2019s disease (PD) and cognitive impairment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A secondary analysis of baseline data from the international Care of Late-Stage Parkinsonism (CLaSP) cohort study was conducted. Participants with PD and either dementia or mild cognitive impairment or MMSE\u2009&lt;\u200924\/30 in the absence of major depression were included if they had completed the EQ-5D-3L assessment (n\u2009=\u2009277). Factors associated with self-rated health (EQ-5D-3L Index and Visual Analogue Scale) were investigated through multivariable linear regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>More severe PD (motor and non-motor) was associated with worse self-rated health. The EQ-5D-3L dimensions of Mobility, Self-Care and Usual Activities were almost universally affected; the latter two particularly severely. Being unable to perform usual activities or having moderate to extreme anxiety or depression were significantly associated with EQ-5D-3L Visual Analogue Scale, suggesting these are particularly valued. Worse motor impairment and function and the non-motor symptom domains of mood, perception, sexual function, and miscellaneous (e.g., pain) were associated with worse self-rated health, whereas greater burden of gastrointestinal symptoms was associated with better self-rated health in multivariate analysis. Better self-rated health was associated with recent PD nurse consultation, and higher doses of dopaminergic medication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Improvement of activities of daily living, mood and anxiety should be prioritised in clinical practice, with consideration of perception and sexual function in this population. Recent nurse consultations and higher antiparkinsonian doses are associated with better self-rated health, suggesting there is no room for a therapeutic nihilism in this population of people within a complex phase of PD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11136-024-03703-2","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T10:02:06Z","timestamp":1718704926000},"page":"2439-2452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors associated with self-rated health in people with late-stage parkinson\u2019s and cognitive impairment"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-7941","authenticated-orcid":false,"given":"Jennifer S.","family":"Pigott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-9393","authenticated-orcid":false,"given":"Megan","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7757-5353","authenticated-orcid":false,"given":"Nathan","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-1955","authenticated-orcid":false,"given":"Daniel","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-3337","authenticated-orcid":false,"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-0821","authenticated-orcid":false,"given":"Stefan","family":"Lorenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2172-7527","authenticated-orcid":false,"given":"Wassilios G.","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0756-7478","authenticated-orcid":false,"given":"Per","family":"Odin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-5113","authenticated-orcid":false,"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2044-6299","authenticated-orcid":false,"given":"Richard","family":"Dodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-6680","authenticated-orcid":false,"given":"Anette","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"3703_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"E Ray Dorsey","year":"2018","unstructured":"Ray Dorsey, E., Elbaz, A., Nichols, E., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J. Y. J., Collado-Mateo, D., Dahodwala, N., Do, H. P., Edessa, D., Endres, M., Fereshtehnejad, S. M., Foreman, K. J., Gankpe, F. G., Gupta, R., Hankey, G. J., \u2026 Murray, C. J. L. (2018). Global, regional, and national burden of parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the global burden of disease study 2016. Lancet Neurology, 17, 939\u2013953. PMID: 30287051.","journal-title":"Lancet Neurology"},{"key":"3703_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrneurol.2012.126","volume":"8","author":"M Coelho","year":"2012","unstructured":"Coelho, M., & Ferreira, J. J. (2012). Late-stage parkinson disease. Nature Reviews. Neurology, 8, 435\u2013442.","journal-title":"Nature Reviews. Neurology"},{"key":"3703_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008). The Sydney multicenter study of parkinson\u2019s disease: The inevitability of dementia at 20 years. Movement Disorders, 23, 837\u2013844. PMID: 18307261.","journal-title":"Movement Disorders"},{"issue":"1","key":"3703_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Chaudhuri, K. R., & Weintraub, D. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7(1), 47.","journal-title":"Nature Reviews Disease Primers"},{"key":"3703_CR5","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/brain\/awm142","volume":"130","author":"PA Kempster","year":"2007","unstructured":"Kempster, P. A., Williams, D. R., Selikhova, M., Holton, J., Revesz, T., & Lees, A. J. (2007). Patterns of levodopa response in parkinson\u2019s disease: A clinico-pathological study. Brain, 130, 2123\u20132128. PMID: 17586867.","journal-title":"Brain"},{"key":"3703_CR6","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.23661","volume":"26","author":"C Vossius","year":"2011","unstructured":"Vossius, C., Larsen, J. P., Janvin, C., & Aarsland, D. (2011). The economic impact of cognitive impairment in parkinson\u2019s disease. Movement Disorders, 26, 1541\u20131544. PMID: 21538519.","journal-title":"Movement Disorders"},{"issue":"6","key":"3703_CR7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/mds.27302","volume":"33","author":"S Weir","year":"2018","unstructured":"Weir, S., Samnaliev, M., Kuo, T.-C., Tierney, T. S., Autiero, S. W., Taylor, R. S., & Schrag, A. (2018). Short- and long-term cost and utilization of health care resources in parkinson\u2019s disease in the UK. Movement Disorders, 33(6), 974\u2013981.","journal-title":"Movement Disorders"},{"key":"3703_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0891988712464823","volume":"25","author":"I Leroi","year":"2012","unstructured":"Leroi, I., McDonald, K., Pantula, H., & Harbishettar, V. (2012). Cognitive impairment in parkinson disease: Impact on quality of life, disability, and caregiver burden. Journal of Geriatric Psychiatry and Neurology, 25, 208\u2013214. PMID: 23172765.","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"3703_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.parkreldis.2014.07.004","volume":"20","author":"RA Lawson","year":"2014","unstructured":"Lawson, R. A., Yarnall, A. J., Duncan, G. W., Khoo, T. K., Breen, D. P., Barker, R. A., Collerton, D., Taylor, J. P., & Burn, D. J. (2014). Severity of mild cognitive impairment in early parkinson\u2019s disease contributes to poorer quality of life. Parkinsonism & Related Disorders, 20, 1071\u20131075. PMID: 25074728.","journal-title":"Parkinsonism & Related Disorders"},{"key":"3703_CR10","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/gps.4623","volume":"32","author":"RA Lawson","year":"2017","unstructured":"Lawson, R. A., Yarnall, A. J., Johnston, F., Duncan, G. W., Khoo, T. K., Collerton, D., Taylor, J. P., & Burn, D. J. (2017). Cognitive impairment in parkinson\u2019s disease: Impact on quality of life of carers. International Journal of Geriatric Psychiatry, 32, 1362\u20131370. PMID: 27925292.","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"1","key":"3703_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/brainsci12010111","volume":"12","author":"K Rosqvist","year":"2022","unstructured":"Rosqvist, K., Schrag, A., Odin, P., & Consortium, C. (2022). Caregiver burden and quality of life in late stage parkinson\u2019s disease. Brain Sciences, 12(1), 111. PMID: 35053854.","journal-title":"Brain Sciences"},{"key":"3703_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.parkreldis.2018.03.027","volume":"52","author":"M Skorvanek","year":"2018","unstructured":"Skorvanek, M., Martinez-martin, P., Kovacs, N., Zezula, I., Rodriguez-violante, M., Corvol, J., Taba, P., Seppi, K., Levin, O., Schrag, A., Aviles-olmos, I., Alvarez-sanchez, M., Arakaki, T., Aschermann, Z., Benchetrit, E., Benoit, C., Bergareche-yarza, A., Cervantes-arriaga, A., Chade, A., \u2026 Stebbins, G. T. (2018). Relationship between the MDS-UPDRS and quality of life: A large multicenter study of 3206 patients. Parkinsonism & Related Disorders, 52, 83\u201389.","journal-title":"Parkinsonism & Related Disorders"},{"key":"3703_CR13","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00415-018-9047-9","volume":"265","author":"M Balzer-Geldsetzer","year":"2018","unstructured":"Balzer-Geldsetzer, M., Klotsche, J., Reetz, K., Spottke, A., Storch, A., Baudrexel, S., Mollenhauer, B., Berg, D., Liepelt, I., Kassubek, J., Kalbe, E., Wittchen, H. U., Dodel, R., & Riedel, O. (2018). Quality of life in a German cohort of parkinson\u2019s patients assessed with three different measures. Journal of Neurology, 265, 2713\u20132722. PMID: 30209651.","journal-title":"Journal of Neurology"},{"key":"3703_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/gps.3970","volume":"29","author":"A Kudlicka","year":"2014","unstructured":"Kudlicka, A., Clare, L., & Hindle, J. V. (2014). Quality of life, health status and caregiver burden in parkinson\u2019s disease: Relationship to executive functioning. International Journal of Geriatric Psychiatry, 29, 68\u201376. PMID: 23625583.","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"3703_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1017\/S0033291799003141","volume":"31","author":"A Schrag","year":"2001","unstructured":"Schrag, A., Jahanshahi, M., & Quinn, N. P. (2001). What contributes to depression in parkinson\u2019s disease? Psychological Medicine, 31, 65\u201373. PMID: 11200961.","journal-title":"Psychological Medicine"},{"issue":"6","key":"3703_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178896","volume":"12","author":"X Tu","year":"2017","unstructured":"Tu, X., Hwang, W., Ma, H., Chang, L., & Hsu, S. (2017). Determinants of generic and specific health- related quality of life in patients with parkinson\u2019s disease. PLoS ONE, 12(6), e0178896.","journal-title":"PLoS ONE"},{"issue":"11","key":"3703_CR17","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s11136-022-03187-y","volume":"31","author":"I Sanchez-Luengos","year":"2022","unstructured":"Sanchez-Luengos, I., Lucas-Jlmenez, O., Ojeda, N., Pena, J., Gomez-Esteban, J. C., Gomez-Beldarraln, M. A., Vazquez-Picon, R., Foncea-Betl, N., & Ibarretxe-Bilbao, N. (2022). Predictors of HrQoL in PD \u2013 impact of overlap in clinical and QoL measures. Quality of Life Research, 31(11), 3241\u20133252.","journal-title":"Quality of Life Research"},{"key":"3703_CR18","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/mds.21567","volume":"22","author":"BL Den Oudsten","year":"2007","unstructured":"Den Oudsten, B. L., Van Heck, G. L., & De Vries, J. (2007). Quality of life and related concepts in parkinson\u2019s disease: A systematic review. Movement Disorders, 22, 1528\u20131537. PMID: 17523198.","journal-title":"Movement Disorders"},{"key":"3703_CR19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s11136-012-0289-1","volume":"22","author":"S-E Soh","year":"2013","unstructured":"Soh, S.-E., McGinley, J. L., Watts, J. J., Iansek, R., Murphy, A. T., Menz, H. B., Huxham, F., & Morris, M. E. (2013). Determinants of health-related quality of life in people with parkinson\u2019s disease: A path analysis. Quality of Life Research, 22, 1543\u20131553.","journal-title":"Quality of Life Research"},{"key":"3703_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jns.2006.05.030","volume":"248","author":"A Schrag","year":"2006","unstructured":"Schrag, A. (2006). Quality of life and depression in parkinson\u2019s disease. Journal of the Neurological Sciences, 248, 151\u2013157.","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"3703_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/jnnp-2019-322379","volume":"91","author":"A Schrag","year":"2020","unstructured":"Schrag, A., & Quinn, N. (2020). What contributes to quality of life in parkinson\u2019s disease: A re-evaluation. Journal of Neurology, Neurosurgery & Psychiatry, 91(6), 563\u2013565. PMID: 32139651.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"3703_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2016.04.009","volume":"27","author":"RA Lawson","year":"2016","unstructured":"Lawson, R. A., Yarnall, A. J., Duncan, G. W., Breen, D. P., Khoo, T. K., Williams-Gray, C. H., Barker, R. A., Collerton, D., Taylor, J. P., & Burn, D. J. (2016). Cognitive decline and quality of life in incident parkinson\u2019s disease: The role of attention. Park. Relat. Disord., 27, 47\u201353. PMID: 27094482.","journal-title":"Park. Relat. Disord."},{"key":"3703_CR23","volume":"2020","author":"M Klietz","year":"2020","unstructured":"Klietz, M., Schnur, T., Drexel, S., Lange, F., Tulke, A., Rippena, L., Paracka, L., Dressler, D., H\u00f6glinger, G. U., Wegner, F., & Portillo, M. C. (2020). Association of motor and cognitive symptoms with health-related quality of life and caregiver burden in a german cohort of advanced parkinson\u2019s disease patients. Parkinson\u2019s Disease, 2020, 5184084.","journal-title":"Parkinson\u2019s Disease"},{"key":"3703_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00269","volume":"12","author":"Y Fan","year":"2020","unstructured":"Fan, Y., Liang, X., Han, L., Shen, Y., Shen, B., Chen, C., Sun, Y., Wang, J., & Tang, Y. (2020). Determinants of quality of life according to cognitive status in parkinson\u2019s disease. Frontiers in Aging Neuroscience, 12, 269.","journal-title":"Frontiers in Aging Neuroscience"},{"key":"3703_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-018-1184-3","volume":"18","author":"M Balzer-Geldsetzer","year":"2018","unstructured":"Balzer-Geldsetzer, M., Ferreira, J., Odin, P., Bloem, B. R., Meissner, W. G., Lorenzl, S., Wittenberg, M., Dodel, R., & Schrag, A. (2018). Study protocol: Care of late-stage parkinsonism (CLaSP): A longitudinal cohort study. BMC Neurology, 18, 1\u20138.","journal-title":"BMC Neurology"},{"issue":"1","key":"3703_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41531-022-00320-z","volume":"8","author":"MC Gonzalez","year":"2022","unstructured":"Gonzalez, M. C., Dalen, I., Maple-Gr\u00f8dem, J., Tysnes, O. B., & Alves, G. (2022). Parkinson\u2019s disease clinical milestones and mortality. NPJ Parkinson\u2019s Disease, 8(1), 58.","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"3703_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQoL group. Annals of Medicine, 33, 337\u2013343. PMID: 11491192.","journal-title":"Annals of Medicine"},{"issue":"3","key":"3703_CR28","doi-asserted-by":"crossref","DOI":"10.1177\/08919887221119963","volume":"36","author":"M Ramadhan","year":"2022","unstructured":"Ramadhan, M., Schrag, A., CLaSP Consortium. (2022). The validity of health-related quality of life instruments in patients with late-stage parkinson\u2019s disease. Journal of geriatric psychiatry and neurology, 36(3), 089198872211199.","journal-title":"Journal of geriatric psychiatry and neurology"},{"key":"3703_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/1536867X1101100108","volume":"11","author":"JM Ramos-Goni","year":"2011","unstructured":"Ramos-Goni, J. M., & Rivero-Arias, O. (2011). eq5d: A command to calculate index values for the EQ-5D quality-of-life instrument. The Stata Journal, 11, 120\u2013125. https:\/\/www.stata-journal.com\/article.html?article=st0220.","journal-title":"The Stata Journal"},{"key":"3703_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/1-4020-5511-0","volume-title":"EQ-5D value sets: Inventory, comparative review and user guide","author":"A Szende","year":"2007","unstructured":"Szende, A., Oppe, M., & Devlin, N. (2007). EQ-5D value sets: Inventory, comparative review and user guide (2007th ed.). Springer.","edition":"2007"},{"key":"3703_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hec.3606","volume":"27","author":"JA Olsen","year":"2018","unstructured":"Olsen, J. A., Lamu, A. N., & Cairns, J. (2018). In search of a common currency: A comparison of seven EQ-5D-5L value sets. Health economics, 27, 39\u201349. PMID: 29063633.","journal-title":"Health economics"},{"issue":"3","key":"3703_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. (1990). EuroQol \u2014 a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands), 16(3), 199\u2013208. PMID: 10109801.","journal-title":"Health policy (Amsterdam, Netherlands)"},{"key":"3703_CR33","unstructured":"StataCorp. (2021). Stata Statistical Software: Release 17."},{"key":"3703_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen, J. C., Gluud, C., Wetterslev, J., & Winkel, P. (2017). When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts. BMC Medical Research Methodology, 17, 1\u201310. PMID: 29207961.","journal-title":"BMC Medical Research Methodology"},{"key":"3703_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur, M. J., Stuart, E. A., Frangakis, C., & Leaf, P. J. (2011). Multiple imputation by chained equations: What is it and how does it work? International Journal of Methods in Psychiatric Research, 20, 40\u201349. PMID: 18543368.","journal-title":"International Journal of Methods in Psychiatric Research"},{"issue":"5","key":"3703_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: onset, progression, and mortality. Neurology, 17(5), 427\u2013442.","journal-title":"Neurology"},{"key":"3703_CR37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/mdc3.13186","volume":"8","author":"K Rosqvist","year":"2021","unstructured":"Rosqvist, K., Odin, P., Lorenzl, S., Meissner, W. G., Bloem, B. R., Ferreira, J. J., Dodel, R., & Schrag, A. (2021). CLaSP consortium, factors associated with health-related quality of life in late-stage parkinson\u2019s disease. Movement Disorders Clinical Practice, 8, 563\u2013570.","journal-title":"Movement Disorders Clinical Practice"},{"key":"3703_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40263-015-0247-x","volume":"29","author":"P Martinez-Martin","year":"2015","unstructured":"Martinez-Martin, P., Rodriguez-Blazquez, C., Forjaz, M. J., & Kurtis, M. M. (2015). Impact of pharmacotherapy on quality of life in patients with parkinson\u2019s disease. CNS Drugs, 29, 397\u2013413.","journal-title":"CNS Drugs"},{"key":"3703_CR39","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/jgs.12027","volume":"60","author":"NJ Weerkamp","year":"2012","unstructured":"Weerkamp, N. J., Zuidema, S. U., Tissingh, G., Poels, P. J. E., Munneke, M., Koopmans, R. T. C. M., & Bloem, B. R. (2012). Motor profile and drug treatment of nursing home residents with parkinson\u2019s disease. Journal of the American Geriatrics Society, 60, 2277\u20132282. PMID: 23231550.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"2","key":"3703_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1212\/CPJ.0000000000000351","volume":"7","author":"Z Goodarzi","year":"2017","unstructured":"Goodarzi, Z., & Ismail, Z. (2017). A practical approach to detection and treatment of depression in parkinson disease and dementia. Neurology Clinical Practice, 7(2), 128\u2013140.","journal-title":"Neurology Clinical Practice"},{"key":"3703_CR41","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/mds.23394","volume":"25","author":"DA Gallagher","year":"2010","unstructured":"Gallagher, D. A., Lees, A. J., & Schrag, A. (2010). What are the most important nonmotor symptoms in patients with parkinson\u2019s disease and are we missing them? Movement Disorders, 25, 2493\u20132500. PMID: 20922807.","journal-title":"Movement Disorders"},{"key":"3703_CR42","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00415-012-6557-8","volume":"259","author":"A Antonini","year":"2012","unstructured":"Antonini, A., Barone, P., Marconi, R., Morgante, L., Zappulla, S., Pontieri, F. E., Ramat, S., Ceravolo, M. G., Meco, G., Cicarelli, G., Pederzoli, M., Manfredi, M., Ceravolo, R., Mucchiut, M., Volpe, G., Abbruzzese, G., Bottacchi, E., Bartolomei, L., Ciacci, G., \u2026 Colosimo, C. (2012). The progression of non-motor symptoms in Parkinson\u2019s disease and their contribution to motor disability and quality of life. Journal of Neurology, 259, 2621\u20132631. PMID: 22711157.","journal-title":"Journal of Neurology"},{"issue":"1","key":"3703_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2020.10.008","volume":"9","author":"CM Santa Rosa Malcher","year":"2021","unstructured":"Santa Rosa Malcher, C. M., da Roberto Silva Gon\u00e7alves Oliveira, K., FernandesCaldato, M. C., Lopes dos Santos Lobato, B., da Silva Pedroso, J., & de Tubino Scanavino, M. (2021). Sexual disorders and quality of life in parkinson\u2019s disease. Sexual medicine, 9(1), 100280.","journal-title":"Sexual medicine"},{"key":"3703_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jns.2011.05.050","volume":"310","author":"G Bronner","year":"2011","unstructured":"Bronner, G. (2011). Sexual problems in parkinson\u2019s disease: The multidimensional nature of the problem and of the intervention. Journal of the Neurological Sciences, 310, 139\u2013143.","journal-title":"Journal of the Neurological Sciences"},{"key":"3703_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clineuro.2012.06.020","volume":"115","author":"P Kotkov\u00e1","year":"2013","unstructured":"Kotkov\u00e1, P., & Weiss, P. (2013). Psychiatric factors related to sexual functioning in patients with parkinson\u2019s disease. Clinical Neurology and Neurosurgery, 115, 419\u2013424. PMID: 22831909.","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"3703_CR46","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/j.1743-6109.2008.01083.x","volume":"6","author":"A Kummer","year":"2009","unstructured":"Kummer, A., Cardoso, F., & Teixeira, A. L. (2009). Loss of libido in parkinson\u2019s disease. The Journal of Sexual Medicine, 6, 1024\u20131031. PMID: 19040621.","journal-title":"The Journal of Sexual Medicine"},{"key":"3703_CR47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/ageing\/afy049","volume":"47","author":"S Vatter","year":"2018","unstructured":"Vatter, S., McDonald, K. R., Stanmore, E., Clare, L., McCormick, S. A., & Leroi, I. (2018). A qualitative study of female caregiving spouses\u2019 experiences of intimate relationships as cognition declines in parkinson\u2019s disease. Age and Ageing, 47, 604\u2013610. PMID: 29617933.","journal-title":"Age and Ageing"},{"key":"3703_CR48","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/bs.irn.2017.05.019","volume":"134","author":"KB Bhattacharyya","year":"2017","unstructured":"Bhattacharyya, K. B., & Rosa-Grilo, M. (2017). Sexual dysfunctions in parkinson\u2019s disease: An underrated problem in a much discussed disorder. International Review of Neurobiology, 134, 859\u2013876.","journal-title":"International Review of Neurobiology"},{"key":"3703_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/2631831820972859","volume":"2","author":"M D\u2019cruz","year":"2020","unstructured":"D\u2019cruz, M., Andrade, C., & Rao, T. S. S. (2020). The expression of intimacy and sexuality in persons with dementia. Journal of Psychosexual Health, 2, 215\u2013223.","journal-title":"Journal of Psychosexual Health"},{"key":"3703_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/308097","volume":"2012","author":"I Leroi","year":"2012","unstructured":"Leroi, I., Pantula, H., Mcdonald, K., Harbishettar, V., Royal, S., Foundation, N. H. S., & Salford, M. (2012). Neuropsychiatric symptoms in parkinson\u2019s disease with mild cognitive impairment and dementia. Parkinson\u2019s Disease, 2012, 1\u201310.","journal-title":"Parkinson\u2019s Disease"},{"key":"3703_CR51","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.parkreldis.2015.03.024","volume":"21","author":"P Martinez-Martin","year":"2015","unstructured":"Martinez-Martin, P., Rodriguez-Blazquez, C., Forjaz, M. J., Frades-Payo, B., Ag\u00fcera-Ortiz, L., Weintraub, D., Riesco, A., Kurtis, M. M., & Chaudhuri, K. R. (2015). Neuropsychiatric symptoms and caregiver\u2019s burden in parkinson\u2019s disease. Parkinsonism & Related Disorders, 21, 629\u2013634. PMID: 25892660.","journal-title":"Parkinsonism & Related Disorders"},{"key":"3703_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14802\/jmd.20079","volume":"14","author":"M Lubomski","year":"2021","unstructured":"Lubomski, M., Davis, R. L., & Sue, C. M. (2021). Health-related quality of life for parkinson\u2019s disease patients and their caregivers. Journal of Movement Disorders, 14, 42\u201352.","journal-title":"Journal of Movement Disorders"},{"issue":"5","key":"3703_CR53","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jclinepi.2006.08.008","volume":"60","author":"JW Shaw","year":"2007","unstructured":"Shaw, J. W., Johnson, J. A., Chen, S., Levin, J. R., & Coons, S. J. (2007). Racial\/ethnic differences in preferences for the EQ-5D health states: results from the U.S. valuation study. Journal of Clinical Epidemiology, 60(5), 479\u2013490. PMID: 17419959.","journal-title":"Journal of Clinical Epidemiology"},{"key":"3703_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-022-02024-7","volume":"20","author":"P Schneider","year":"2022","unstructured":"Schneider, P., Love-Koh, J., McNamara, S., Doran, T., & Gutacker, N. (2022). Socioeconomic inequalities in HRQoL in England: An age-sex stratified analysis. Health and Quality of Life Outcomes, 20, 1\u20139. PMID: 35918765.","journal-title":"Health and Quality of Life Outcomes"},{"key":"3703_CR55","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1007\/s11136-022-03158-3","volume":"31","author":"I Buchholz","year":"2022","unstructured":"Buchholz, I., Marten, O., & Janssen, M. F. (2022). Feasibility and validity of the EQ-5D-3L in the elderly Europeans: A secondary data analysis using SHARE(d) data. Quality of Life Research, 31, 3267\u20133282. PMID: 35624409.","journal-title":"Quality of Life Research"},{"key":"3703_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ane.12695","volume":"136","author":"K Rosqvist","year":"2017","unstructured":"Rosqvist, K., Hagell, P., Odin, P., Ekstr\u00f6m, H., Iwarsson, S., & Nilsson, M. H. (2017). Factors associated with life satisfaction in parkinson\u2019s disease. Acta Neurologica Scandinavica, 136, 64\u201371. PMID: 27726132.","journal-title":"Acta Neurologica Scandinavica"},{"key":"3703_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-014-0193-0","volume":"14","author":"A Gison","year":"2014","unstructured":"Gison, A., Rizza, F., Bonassi, S., Dall\u2019Armi, V., Lisi, S., & Giaquinto, S. (2014). The sense-of-coherence predicts health-related quality of life and emotional distress but not disability in Parkinson\u2019s disease. BMC Neurology, 14, 1\u20136. PMID: 25304029.","journal-title":"BMC Neurology"},{"key":"3703_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40273-020-00893-8","volume":"38","author":"AJ Thompson","year":"2020","unstructured":"Thompson, A. J., & Turner, A. J. (2020). A comparison of the EQ-5D-3L and EQ-5D-5L. PharmacoEconomics, 38, 575\u2013591.","journal-title":"PharmacoEconomics"},{"key":"3703_CR59","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010). Systematic review of levodopa dose equivalency reporting in parkinson\u2019s disease. Movement Disorders, 25, 2649\u20132685.","journal-title":"Movement Disorders"},{"key":"3703_CR60","volume-title":"Recent Developments in Parkinson\u2019s Disease","author":"S Fahn","year":"1987","unstructured":"Fahn, S., Elton, R., Members of the UPDRS Development Committee. (1987). Unified parkinson\u2019s disease rating scale. In S. Fahn, C. Marsden, M. Goldstein, & D. Calne (Eds.), Recent Developments in Parkinson\u2019s Disease.  (Vol. 2). Florhan Park, NJ: Macmillan Healthcare Information."},{"issue":"3","key":"3703_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189\u2013198.","journal-title":"Journal of Psychiatric Research"},{"issue":"13","key":"3703_CR62","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri, K. R., Martinez-Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Abe, K., MacPhee, G., MacMahon, D., Barone, P., Rabey, M., Forbes, A., Breen, K., Tluk, S., Naidu, Y., Olanow, W., Williams, A. J., Thomas, S., \u2026 Schapira, A. H. V. (2007). The metric properties of a novel non-motor symptoms scale for parkinson s disease. Movement Disorders, 22(13), 1901\u20131911.","journal-title":"Movement Disorders"},{"issue":"2","key":"3703_CR63","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.euroneuro.2010.08.002","volume":"21","author":"S Von Campenhausen","year":"2011","unstructured":"Von Campenhausen, S., Winter, Y., Rodriguese Silva, A., Sampaio, C., Ruzicka, E., Barone, P., Poewe, W., Guekht, A., Mateus, C., Pfeiffer, K.-P., Berger, K., Skoupa, J., B\u00f6tzel, K., Geiger-Gritsch, S., Siebert, U., Balzer-Geldsetzer, M., Oertel, W. H., Dodel, R., & Reese, J. P. (2011). Costs of illness and care in parkinson\u2019s disease: An evaluation in six countries. European Neuropsychopharmacology, 21(2), 180\u2013191.","journal-title":"European Neuropsychopharmacology"},{"key":"3703_CR64","first-page":"152","volume-title":"Third Symposium on Parkinson\u2019s Disease","author":"R Schwab","year":"1969","unstructured":"Schwab, R., & England, A. (1969). Projection technique for evaluating surgery in Parkinson\u2019s disease. In F. H. Billingham & M. C. Donaldson (Eds.), Third Symposium on Parkinson\u2019s Disease (pp. 152\u2013157). Edinburgh: Churchill Livingstone."},{"key":"3703_CR65","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit, S. H., Reever, K. E., & Bach-Peterson, J. (1980). Relatives of the impaired elderly: Correlates of feelings of burden. The Gerontologist, 20, 649\u2013655.","journal-title":"The Gerontologist"},{"key":"3703_CR66","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10198-021-01326-9","volume":"22","author":"MF Janssen","year":"2021","unstructured":"Janssen, M. F., Pickard, A. S., & Shaw, J. W. (2021). General population normative data for the EQ-5D-3L in the five largest European economies. The European Journal of Health Economics, 22, 1467\u20131475. PMID: 34117986.","journal-title":"The European Journal of Health Economics"},{"key":"3703_CR67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ageing\/afy155","volume":"48","author":"SM Nelis","year":"2019","unstructured":"Nelis, S. M., Wu, Y. T., Matthews, F. E., Martyr, A., Quinn, C., Rippon, I., Rusted, J., Thom, J. M., Kopelman, M. D., Hindle, J. V., Jones, R. W., & Clare, L. (2019). The impact of co-morbidity on the quality of life of people with dementia: Findings from the IDEAL study. Age and Ageing, 48, 361\u2013367. PMID: 30403771.","journal-title":"Age and Ageing"},{"key":"3703_CR68","unstructured":"Canadian Agency for Drugs and Technologies in Health. (2018). Clinical Review Report \u2013 Levodopa\/Carbidopa. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539562\/pdf\/Bookshelf_NBK539562.pdf."},{"key":"3703_CR69","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mds.26123","volume":"30","author":"HH Fernandez","year":"2015","unstructured":"Fernandez, H. H., Standaert, D. G., Hauser, R. A., Lang, A. E., Fung, V. S. C., Klostermann, F., Lew, M. F., Odin, P., Steiger, M., Yakupov, E. Z., Chouinard, S., Suchowersky, O., Dubow, J., Hall, C. M., Chatamra, K., Robieson, W. Z., Benesh, J. A., & Espay, A. J. (2015). Levodopa-carbidopa intestinal gel in advanced parkinson\u2019s disease: Final 12-month, open-label results. Movement Disorders, 30, 500\u2013509. PMID: 25545465.","journal-title":"Movement Disorders"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03703-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-024-03703-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03703-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T14:14:52Z","timestamp":1726064092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-024-03703-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3703"],"URL":"https:\/\/doi.org\/10.1007\/s11136-024-03703-2","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]},"assertion":[{"value":"28 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethical committees of all participating study sites (London, Camden, and Islington NRES Committees 14\/LO\/0612; Bordeaux, South West, and Overseas Protection Committee III [South West and Overseas Protection Committee], 2014-A01501\u201346; Lisbon, Centro Hospitalar Lisboa Norte, DIRCLN-19SET2014\u2013 275; Lund, EPN regional ethics name Lund, JPND NC 559\u2013002; Marburg, Ethics Commission at the State Medical Association Hesse, MC 309\/2014; Munich, ethics committee at the LMU Munchen, 193\u201314; Nijmegen, Radboud University Medical Center, Group Staff Quality and Safety Human Research Committee, Arnhem-Nijmegen region, DJ\/CMO300). To obtain consent, detailed oral and written information were given to the patients and their informant to ensure that the patient fully understood the potential risks and benefits of the study. If patients were unable to provide consent, consent was obtained with the legal representative, in accordance with national law.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained for all individual participants included in the study: from the participant themselves if they had capacity, or from a legal guardian, in accordance with local ethical and legal regulations, if participants lacked capacity.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}